Skip to main content
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · IEX Real-Time Price · USD
12.02
+0.33 (2.82%)
At close: May 3, 2024, 4:00 PM
12.26
+0.24 (2.00%)
After-hours: May 3, 2024, 7:42 PM EDT

Stoke Therapeutics Revenue

In the year 2023, Stoke Therapeutics had annual revenue of $8.78M, a decrease of -29.22%. Revenue in the quarter ending December 31, 2023 was $2.80M, a -14.26% decrease year-over-year.

Revenue (ttm)
$8.78M
Revenue Growth
-29.22%
P/S Ratio
71.35
Revenue / Employee
$79,818
Employees
110
Market Cap
626.45M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.78M-3.63M-29.22%
Dec 31, 202212.41M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 855.80M
The Pennant Group 544.89M
Accolade 414.29M
Fulgent Genetics 287.53M
Zymeworks 50.46M
IGM Biosciences 2.13M
Lyell Immunopharma 130.00K
Revenue Rankings

STOK News

More News